CLOs on the Move

Cyteir

www.cyteir.com

 
Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir`s wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug currently in a Phase 1/2 clinical trial for hematologic and solid tumors.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cyteir.com
  • 128 Spring Street Building A, Suite 510
    Lexington, MA USA 02421
  • Phone: 857.285.4140

Executives

Name Title Contact Details
Adam Veness
 General Counsel Profile

Similar Companies

Advanced Care Scripts

Advanced Care Scripts is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Janssen-Ortho

Janssen-Ortho Inc. is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Diversatek

Almirall

With over 1,975 employees, it has a presence, through its 13 affiliates in Europe and United States.

Adjuvants Plus Inc

Adjuvants Plus Inc is a Kingsville, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.